Derek Hicks, EVP, Chief Business Officer at Intellia Therapeutics, Inc. (NTLA), sold 13,004 shares at $12.18 ($158K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Seasonal sale ($158k) by EVP, Chief Business Officer — this insider has traded NTLA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.18 | 6,502 | $79K | 50.0% |
| 2 | $12.18 | 6,502 | $79K | 50.0% |
| Total | $12.18 avg | 13,004 | $158K | 100% |
| Filing → |